Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1301262	BGB-283	lifirafenib	Active ingredient	Chemical Drugs(1.1)	New Drug Application	2014-05-20	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	Certificate Issued	2015-07-27	view
CXHL1301261	BGB-283胶囊	lifirafenib	Capsule	Chemical Drugs(1.1)	New Drug Application	2014-05-20	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	Certificate Issued	2015-07-27	view
CXHL1301260	BGB-283胶囊	lifirafenib	Capsule	Chemical Drugs(1.1)	New Drug Application	2014-05-20	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	Certificate Issued	2015-07-27	view
CXHL1301259	BGB-283胶囊	lifirafenib	Capsule	Chemical Drugs(1.1)	New Drug Application	2014-05-20	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	Certificate Issued	2015-07-27	view